LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 19 Oct 2026
MHRA approval

plozasiran (Redemplo)

Published on 19 Oct 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)
MHRA announcement ↗ All events: plozasiran (Redemplo)

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.